Omeprazole Blocks STAT6 Binding to the Eotaxin-3 Promoter in Eosinophilic Esophagitis Cells

被引:145
|
作者
Zhang, Xi [1 ,2 ]
Cheng, Edaire [2 ,4 ]
Huo, Xiaofang [1 ,2 ]
Yu, Chunhua [1 ,2 ]
Zhang, Qiuyang [1 ,2 ]
Pham, Thai H. [2 ,3 ]
Wang, David H. [1 ,2 ,5 ]
Spechler, Stuart J. [1 ,2 ]
Souza, Rhonda F. [1 ,2 ,5 ]
机构
[1] Vet Affairs N Texas Hlth Care Syst, Dept Internal Med, Dallas, TX 75216 USA
[2] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[3] Vet Affairs N Texas Hlth Care Syst, Dept Surg, Dallas, TX USA
[4] Childrens Med Ctr, Dept Pediat, Dallas, TX 75235 USA
[5] Harold C Simmons Comprehens Canc Ctr, Dallas, TX USA
来源
PLOS ONE | 2012年 / 7卷 / 11期
基金
美国国家卫生研究院;
关键词
GASTROESOPHAGEAL-REFLUX DISEASE; GENE-EXPRESSION; CONSENSUS RECOMMENDATIONS; EPITHELIAL-CELLS; ACTIVATION; ACIDIFICATION; ASSOCIATION; CHILDREN; ATPASE; ADULTS;
D O I
10.1371/journal.pone.0050037
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Patients who have esophageal eosinophilia without gastroesophageal reflux disease (GERD) nevertheless can respond to proton pump inhibitors (PPIs), which can have anti-inflammatory actions independent of effects on gastric acid secretion. In esophageal cell cultures, omeprazole has been reported to inhibit Th2 cytokine-stimulated expression of eotaxin-3, an eosinophil chemoattractant contributing to esophageal eosinophilia in eosinophilic esophagitis (EoE). The objective of this study was to elucidate molecular mechanisms underlying PPI inhibition of IL-4-stimulated eotaxin-3 production by esophageal cells. Methods/Findings: Telomerase-immortalized and primary cultures of esophageal squamous cells from EoE patients were treated with IL-4 in the presence or absence of acid-activated omeprazole or lansoprazole. We measured eotaxin-3 protein secretion by ELISA, mRNA expression by PCR, STAT6 phosphorylation and nuclear translocation by Western blotting, eotaxin-3 promoter activation by an exogenous reporter construct, and STAT6, RNA polymerase II, and trimethylated H3K4 binding to the endogenous eotaxin-3 promoter by ChIP assay. Omeprazole in concentrations >= 5 mu M significantly decreased IL-4-stimulated eotaxin-3 protein secretion and mRNA expression. Lansoprazole also blocked eotaxin-3 protein secretion. Omeprazole had no effect on eotaxin-3 mRNA stability or on STAT6 phosphorylation and STAT6 nuclear translocation. Rather, omeprazole blocked binding of IL-4-stimulated STAT6, RNA polymerase II, and trimethylated H3K4 to the eotaxin-3 promoter. Conclusions/Significance: PPIs, in concentrations achieved in blood with conventional dosing, significantly inhibit IL-4-stimulated eotaxin-3 expression in EoE esophageal cells and block STAT6 binding to the promoter. These findings elucidate molecular mechanisms whereby patients with Th2 cytokine-driven esophageal eosinophilia can respond to PPIs, independent of effects on gastric acid secretion.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] in Esophageal Squamous Epithelial Cells From Patients With EoE, Omeprazole Blocks Cytokine-Stimulated Eotaxin-3 Secretion by Reducing Binding of STAT6 to the Eotaxin-3 Promoter.
    Zhang, Xi
    Cheng, Edaire
    Huo, Xiaofang
    Wang, David H.
    Zhang, Qiuyang
    Yu, Chunhua
    Spechler, Stuart J.
    Souza, Rhonda F.
    GASTROENTEROLOGY, 2012, 142 (05) : S116 - S117
  • [2] Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD
    Cheng, Edaire
    Zhang, Xi
    Huo, Xiaofang
    Yu, Chunhua
    Zhang, Qiuyang
    Wang, David H.
    Spechler, Stuart Jon
    Souza, Rhonda F.
    GUT, 2013, 62 (06) : 824 - 832
  • [3] STAT6 phosphorylation inhibitors block eotaxin-3 secretion in bronchial epithelial cells
    Zhou, Li
    Kawate, Tomohiko
    Liu, Xiaorong
    Kim, Young Bae
    Zhao, Yajuan
    Feng, Guohong
    Banerji, Julian
    Nash, Huw
    Whitehurst, Charles
    Jindal, Satish
    Siddiqui, Arshad
    Seed, Brian
    Wolfe, Jia L.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (02) : 750 - 758
  • [4] Eotaxin-3 immunofluorescence in children and adults with eosinophilic esophagitis
    Frech, Edward J.
    Go, Mae F.
    Thomas, Kristen
    Lowichik, Amy
    Peterson, Kathryn A.
    GASTROENTEROLOGY, 2008, 134 (04) : A730 - A730
  • [5] Activation of eotaxin-3/CCL26 gene in human enterocytes is mediated by STAT6
    Blanchard, C
    Durual, S
    Boncoeur, E
    Estienne, M
    Cuber, JC
    GASTROENTEROLOGY, 2002, 122 (04) : A110 - A110
  • [6] Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis
    Blanchard, C
    Wang, N
    Stringer, KF
    Mishra, A
    Fulkerson, PC
    Abonia, JP
    Jameson, SC
    Kirby, C
    Konikoff, MR
    Collins, MH
    Cohen, MB
    Akers, R
    Hogan, SP
    Assa'ad, AH
    Putnam, PE
    Aronow, BJ
    Rothenberg, ME
    JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (02): : 536 - 547
  • [7] Eosinophilic esophagitis: Study of pathogenesis, stem cell proliferation and biomarker eotaxin-3
    Patil, D. T.
    Zhang, M.
    Liao, J.
    Rao, M. S.
    King, G-Y
    LABORATORY INVESTIGATION, 2007, 87 : 127A - 127A
  • [8] Eosinophilic esophagitis: Study of pathogenesis, stem cell proliferation and biomarker eotaxin-3
    Patil, D. T.
    Zhang, M.
    Liao, J.
    Rao, M. S.
    Yang, G-Y
    MODERN PATHOLOGY, 2007, 20 : 127A - 127A
  • [9] Stat6 Activation and Periostin Expression in Eosinophilic Esophagitis Versus Reflux Esophagitis
    Chandler, W. M.
    Kuwada, S. K.
    Clayton, F. C.
    LABORATORY INVESTIGATION, 2009, 89 : 126A - 126A
  • [10] IL-13 is overexpressed in eosinophilic esophagitis and induces eotaxin-3 expression in esophageal epithelial cells
    Blanchard, C.
    Mingler, M. K.
    Putnam, P.
    Rothenberg, M. E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S240 - S240